Avricore Health Inc
XTSX:AVCR
Avricore Health Inc
XTSX:AVCR
Price:
0.065
CAD
-7.14%
Market Closed
Market Cap:
CA$6.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avricore Health Inc
XTSX:AVCR
|
CA |
|
S
|
Sirius XM Holdings Inc
XETRA:RDO
|
US |
|
Synchronoss Technologies Inc
NASDAQ:SNCR
|
US |
|
Tclarke PLC
LSE:CTO
|
UK |
|
B
|
Bikurey Hasade Holdings Ltd
TASE:BKRY
|
IL |
|
Ricegrowers Ltd
ASX:SGLLV
|
AU |
|
Sunstone Hotel Investors Inc
NYSE:SHO
|
US |
|
C
|
ChipMOS Technologies Inc
TWSE:8150
|
TW |
|
S
|
Standard Bank Group Ltd
JSE:SBK
|
ZA |
|
G
|
Gujarat Lease Financing Ltd
NSE:GLFL
|
IN |
|
Zinc of Ireland NL
ASX:ZMI
|
AU |
|
Perrigo Company PLC
NYSE:PRGO
|
IE |
|
C
|
Cover 50 SpA
MIL:COV
|
IT |
|
Mackenzie Realty Capital Inc
OTC:MKZR
|
US |
|
Wee-Cig International Corp
OTC:WCIG
|
US |
|
Kyushu Electric Power Co Inc
TSE:9508
|
JP |
|
Xenetic Biosciences Inc
NASDAQ:XBIO
|
US |
|
Qingdao Vland Biotech INC
SSE:603739
|
CN |
|
T
|
Tri Viet Asset Management Corporation JSC
VN:TVC
|
VN |
|
G
|
Gogoro Inc
NASDAQ:GGR
|
TW |
|
R
|
Rex Trueform Group Ltd
JSE:RTO
|
ZA |
|
Lycopodium Ltd
ASX:LYL
|
AU |
Balance Sheet
Balance Sheet Decomposition
Avricore Health Inc
Avricore Health Inc
Balance Sheet Decomposition is not available for
Avricore Health Inc
Avricore Health Inc
Balance Sheet
Avricore Health Inc
Avricore Health Inc
Currency: CAD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
|
| Cash Equivalents |
2
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
2
|
2
|
1
|
0
|
0
|
2
|
1
|
1
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
2
-35%
|
3
+27%
|
1
-59%
|
0
-83%
|
0
+111%
|
2
+418%
|
3
+13%
|
3
-1%
|
2
-9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+45%
|
0
+13%
|
0
-22%
|
1
+114%
|
1
+71%
|
0
-93%
|
1
+616%
|
1
-13%
|
0
-37%
|
|
| Equity | |||||||||||
| Common Stock |
16
|
16
|
19
|
21
|
22
|
22
|
27
|
27
|
27
|
27
|
|
| Retained Earnings |
13
|
14
|
17
|
20
|
22
|
23
|
24
|
25
|
25
|
25
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
2
-41%
|
2
+30%
|
1
-65%
|
0
N/A
|
1
-53%
|
2
N/A
|
2
-11%
|
2
+2%
|
2
-2%
|
|
| Total Liabilities & Equity |
3
N/A
|
2
-35%
|
3
+27%
|
1
-59%
|
0
-83%
|
0
+111%
|
2
+418%
|
3
+13%
|
3
-1%
|
2
-9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
14
|
15
|
28
|
40
|
52
|
70
|
98
|
99
|
100
|
101
|
|
Switch to:
Switch to:
See Also
Discover More
